JPH0587081B2 - - Google Patents
Info
- Publication number
- JPH0587081B2 JPH0587081B2 JP63105346A JP10534688A JPH0587081B2 JP H0587081 B2 JPH0587081 B2 JP H0587081B2 JP 63105346 A JP63105346 A JP 63105346A JP 10534688 A JP10534688 A JP 10534688A JP H0587081 B2 JPH0587081 B2 JP H0587081B2
- Authority
- JP
- Japan
- Prior art keywords
- cellulose
- particles
- particle size
- average particle
- number average
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002245 particle Substances 0.000 claims description 102
- 229920002678 cellulose Polymers 0.000 claims description 61
- 239000001913 cellulose Substances 0.000 claims description 60
- 238000009826 distribution Methods 0.000 claims description 18
- 238000001179 sorption measurement Methods 0.000 description 18
- 239000004627 regenerated cellulose Substances 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 239000003463 adsorbent Substances 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 102000004506 Blood Proteins Human genes 0.000 description 9
- 108010017384 Blood Proteins Proteins 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 102000009027 Albumins Human genes 0.000 description 6
- 108010088751 Albumins Proteins 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000008081 blood perfusion Effects 0.000 description 5
- 239000000701 coagulant Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 206010018910 Haemolysis Diseases 0.000 description 4
- 230000008588 hemolysis Effects 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 229920001747 Cellulose diacetate Polymers 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 102000016943 Muramidase Human genes 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000004325 lysozyme Substances 0.000 description 3
- 229960000274 lysozyme Drugs 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- DQEFEBPAPFSJLV-UHFFFAOYSA-N Cellulose propionate Chemical compound CCC(=O)OCC1OC(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C1OC1C(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C(COC(=O)CC)O1 DQEFEBPAPFSJLV-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 229920006218 cellulose propionate Polymers 0.000 description 2
- 230000001112 coagulating effect Effects 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 238000005192 partition Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- ALWXETURCOIGIZ-UHFFFAOYSA-N 1-nitropropylbenzene Chemical compound CCC([N+]([O-])=O)C1=CC=CC=C1 ALWXETURCOIGIZ-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920008347 Cellulose acetate propionate Polymers 0.000 description 1
- 101001032022 Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787) Hydroxylamine reductase 2 Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 229920001727 cellulose butyrate Polymers 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- QKSIFUGZHOUETI-UHFFFAOYSA-N copper;azane Chemical compound N.N.N.N.[Cu+2] QKSIFUGZHOUETI-UHFFFAOYSA-N 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 150000002023 dithiocarboxylic acids Chemical class 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 238000004810 partition chromatography Methods 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000000352 supercritical drying Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Processes Of Treating Macromolecular Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は特定の数平均粒径を有し、粒径分布が
せまく、かつ特定の分配係数を有するセルロース
系粒子に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to cellulose-based particles having a specific number average particle size, a narrow particle size distribution, and a specific distribution coefficient.
セルロース、再生セルロース、セルロース誘導
体などのセルロース系の材料は、血球成分や血漿
蛋白質の非特異吸着が比較的少ないなどの特徴を
有する。それゆえ、セルロース系の材料、とくに
これら材料で被覆された数平均粒径600〜1500μm
程度の活性炭粒子が、血液中から血漿蛋白質など
を選択的に除去するために用いられている。ただ
し、セルロース系粒子自体がこの目的に使用され
たことはかつてなかつた。
Cellulose-based materials such as cellulose, regenerated cellulose, and cellulose derivatives are characterized by relatively low nonspecific adsorption of blood cell components and plasma proteins. Therefore, cellulosic materials, especially those coated with a number average particle size of 600 to 1500 μm,
Activated carbon particles are used to selectively remove plasma proteins and the like from blood. However, cellulosic particles themselves have never been used for this purpose.
一方、球状ポリマー粒子の製造方法として分散
法とスプレー法が知られている。 On the other hand, dispersion methods and spray methods are known as methods for producing spherical polymer particles.
分散法では、界面活性剤を含む分散媒体中に小
滴状に分散させたポリマーの希薄溶液からその溶
剤を揮発させることによつて固化させるか(特開
昭56−24430号公報参照)、この分散液に小滴の凝
固剤を徐々に加えて固化させるかする(特開昭57
−159801号公報参照)ことによつてポリマー粒子
がえられる。この方法では広い粒径分布を有する
粒子がえられる上、固化した小滴から溶剤、分散
媒体および界面活性剤を除くために水だけでなく
有機溶剤による洗浄が必要である。 In the dispersion method, a dilute solution of a polymer dispersed in small droplets in a dispersion medium containing a surfactant is solidified by evaporating the solvent (see Japanese Patent Application Laid-Open No. 56-24430); Gradually add small droplets of a coagulant to the dispersion liquid to solidify it (Japanese Patent Application Laid-Open No. 1983-1999)
-159801)), polymer particles can be obtained. This method yields particles with a broad size distribution and requires washing with organic solvents as well as water to remove solvent, dispersion medium and surfactants from the solidified droplets.
スプレー法では、ポリマー溶液を凝固剤中に噴
霧することによつてポリマー粒子がえられる。こ
の粒子も広い粒径分布を持ち、また粒径も比較的
大きい(特開昭52−129788号公報参照)。 In the spray method, polymer particles are obtained by spraying a polymer solution into a coagulant. These particles also have a wide particle size distribution and are relatively large in size (see Japanese Patent Application Laid-Open No. 129788/1983).
前記球状ポリマー粒子としてセルロース系粒子
を製造し、セルロース系材料で被覆された活性炭
粒子のかわりに用いようとしたばあい、セルロー
ス系粒子に粒径の小さいものが多く含まれると、
吸着効率の良好なカラム状の吸着体として用いた
ばあいに圧力損失が大きくなり、溶血などの問題
が生ずる、分画分子量がシヤープでなくなるので
選択性がわるくなる、などの問題が生ずる。 If cellulose-based particles are produced as the spherical polymer particles and intended to be used in place of activated carbon particles coated with cellulose-based material, if the cellulose-based particles contain many small particles,
When used as a column-shaped adsorbent with good adsorption efficiency, problems arise such as a large pressure loss, causing problems such as hemolysis, and poor selectivity because the molecular weight cutoff is no longer sharp.
また、セルロース系粒子に粒径の大きいものが
多く含まれると、粒子の比表面積(粒子の単位体
積当りの粒子総表面積)が小さくなるので吸着速
度が低下するという問題が生ずる。 Furthermore, if the cellulose-based particles contain many large particles, the specific surface area of the particles (the total surface area of the particles per unit volume of the particles) becomes small, resulting in a problem that the adsorption rate decreases.
本発明は前記諸問題の原因であるセルロース系
粒子の粒径分布が広いなどの問題を解消するため
になされたものであり、数平均粒径が300〜
600μmの範囲にあり、95%以上の粒子が数平均粒
径の±10%以内にあり、分配係数が分子量10000
以下に対して0.3以上、分子量100000以上に対し
て0.05以下であるセルロース系粒子に関する。
The present invention was made in order to solve the problems such as the wide particle size distribution of cellulose particles, which is the cause of the above problems, and the number average particle size is 300 to 300.
600μm range, more than 95% of particles are within ±10% of the number average particle size, and the distribution coefficient is molecular weight 10000.
Regarding cellulose particles having a molecular weight of 0.3 or more for the following, and 0.05 or less for a molecular weight of 100,000 or more.
本発明のセルロース系粒子は、セルロース、再
生セルロース、セルロース誘導体などのセルロー
ス系の材料から構成されている。それゆえ、該セ
ルロース系粒子を血液中から血漿蛋白質などを選
択的に除去するなどの用途に用いたばあいには、
他の材料からの粒子を用いたばあいと比較して血
球成分や血漿蛋白質の非特異吸着が少なくなる。
また生化学物質のクロマトグラフイーによる分取
などの用途に用いたばあいにも、蛋白質の非特異
吸着が少なくなる。
The cellulose-based particles of the present invention are composed of cellulose-based materials such as cellulose, regenerated cellulose, and cellulose derivatives. Therefore, when the cellulose-based particles are used for purposes such as selectively removing plasma proteins from blood,
Nonspecific adsorption of blood cell components and plasma proteins is reduced compared to when particles made from other materials are used.
Furthermore, when used for applications such as preparative separation of biochemical substances by chromatography, non-specific adsorption of proteins is reduced.
前記セルロースとは、いわゆる天然セルロース
のことであり、たとえば木綿繊維を脱脂したも
の、麻類の繊維、木材からリグニンやヘミセルロ
ースなどを除去してえられるパルプ、該パルプを
さらに精製してえられる精製セルロースなどがそ
の代表例としてあげられるが、これらに限定され
るものではない。 The above-mentioned cellulose refers to so-called natural cellulose, such as pulp obtained by removing lignin and hemicellulose from defatted cotton fibers, hemp fibers, and wood, and refined pulp obtained by further refining the pulp. Typical examples include cellulose, but are not limited to these.
また前記セルロース誘導体とは、たとえばセル
ロースの水酸基の一部または全部がエステル化や
エーテル化などされたもの、セルロースの水酸基
の一部がエステル化され、一部がエーテル化され
たものなど、セルロースから誘導されたもののこ
とである。 The cellulose derivatives are derived from cellulose, such as those in which some or all of the hydroxyl groups of cellulose have been esterified or etherified, and those in which some of the hydroxyl groups of cellulose have been esterified and some have been etherified. It is something that has been induced.
前記セルロースの水酸基の一部または全部がエ
ステル化されたものの具体例としては、たとえば
酢酸セルロース、プロピオン酸セルロース、酪酸
セルロース、ニトロセルロース、硫酸セルロー
ス、リン酸セルロース、酢酸酪酸セルロース、硝
酸セルロース、セルロースのジチオカルボン酸エ
ステル(ビスコースレーヨン)などがあげられる
が、これに限定されるものではない。 Specific examples of cellulose in which some or all of the hydroxyl groups have been esterified include cellulose acetate, cellulose propionate, cellulose butyrate, cellulose nitro, cellulose sulfate, cellulose phosphate, cellulose acetate butyrate, cellulose nitrate, and cellulose cellulose. Examples include, but are not limited to, dithiocarboxylic acid esters (viscose rayon).
前記セルロースの水酸基の一部または全部がエ
ーテル化されたものの具体例としては、たとえば
メチルセルロース、エチルセルロース、ベンジル
セルロース、トリチルセルロース、シアンエチル
セルロース、カルボキシメチルセルロース、カル
ボキシエチルセルロース、アミノエチルセルロー
ス、オキシエチルセルロースなどがあげられる
が、これらに限定されるものではない。 Specific examples of cellulose in which some or all of the hydroxyl groups are etherified include methylcellulose, ethylcellulose, benzylcellulose, tritylcellulose, cyanethylcellulose, carboxymethylcellulose, carboxyethylcellulose, aminoethylcellulose, oxyethylcellulose, etc. , but not limited to these.
さらに前記再生セルロースとは、セルロースを
一担成形しやすいセルロース誘導体にして成形し
たのち、加水分解などによりセルロースを再生さ
せたセルロースのことである。 Furthermore, the regenerated cellulose refers to cellulose obtained by molding cellulose into a cellulose derivative that can be easily molded in one piece, and then regenerating the cellulose by hydrolysis or the like.
前記セルロース系粒子を構成するセルロース系
材料のうちでは、精製セルロースが不純物が少な
く、溶解したとき非溶解物が少ないなどの点から
好ましく、酢酸セルロース、プロピオン酸セルロ
ースなどのセルロースエステルが、多種の溶剤に
溶解するため、粒子製造時の種々の製造条件の選
択範囲も広くなり、粒子の分配係数やスキン層の
厚さ、内部の網目状組織における孔の大きさなど
の調整が容易となり、所望のセルロース系粒子を
製造しうるなどという点から好ましく、さらに加
水分解することによつて容易に再生セルロース粒
子にすることもできるという点から一層好まし
い。 Among the cellulose-based materials constituting the cellulose-based particles, purified cellulose is preferable because it has fewer impurities and leaves less undissolved matter when dissolved, and cellulose esters such as cellulose acetate and cellulose propionate are suitable for use in various solvents. As a result, the range of selection of various manufacturing conditions during particle production is widened, and it is easy to adjust the particle distribution coefficient, skin layer thickness, pore size in the internal network structure, etc. to achieve the desired result. This is preferable because cellulose-based particles can be produced, and it is even more preferable because it can be easily converted into regenerated cellulose particles by hydrolysis.
本発明のセルロース系粒子は、球状(ほぼ真球
のもののみならず、短径/長径が0.8程度までの
楕円状のものの回転体などをも含む概念である)
の粒子であり、数平均粒径(楕円状回転体のばあ
いには体積平均粒径、すなわち長径の2乗に短径
を乗じた値の3乗根として求める)が300〜
600μmの範囲にあり、95%以上の粒子が数平均粒
径の±10%以内にあり、かつ分配係数が分子量
10000以下に対して0.3以上、分子量100000以上に
対して0.05以下である。このようなセルロース系
粒子の表面には、通常10μm以下の厚さのスキン
層が存在し、内部は0.1〜10μmの孔を有する網目
状組織からなつている。また粒子の空孔率は50〜
95%程度である。 The cellulose-based particles of the present invention are spherical (a concept that includes not only almost perfect spheres but also ellipsoidal bodies of rotation with a short axis/long axis of up to about 0.8).
, and the number average particle diameter (in the case of an elliptical rotating body, the volume average particle diameter, which is determined as the cube root of the square of the major axis multiplied by the minor axis) is 300~
600μm range, 95% or more of the particles are within ±10% of the number average particle size, and the distribution coefficient is within the molecular weight range.
It is 0.3 or more for a molecular weight of 10,000 or less, and 0.05 or less for a molecular weight of 100,000 or more. On the surface of such cellulose-based particles, there is usually a skin layer with a thickness of 10 μm or less, and the inside is composed of a network structure having pores of 0.1 to 10 μm. In addition, the porosity of the particles is 50~
It is about 95%.
第1図および第2図は本発明のセルロース系粒
子のスキン層(第1図の上端左から約1/3の部分
から左端上から約1/2の部分にかけて斜に存在す
る白つぽい層のうちの表面部分)およびその内側
の網目状構造を観察した電子顕微鏡写真(15000
倍)の例である。 Figures 1 and 2 show the skin layer of the cellulose-based particles of the present invention (a whitish layer that exists diagonally from about 1/3 from the top left in Figure 1 to about 1/2 from the top left). Electron micrograph (15,000
This is an example of
前記数平均粒径が300μm未満になると、血液中
から血漿蛋白質を選択的に除くための吸着体用の
セルロース系粒子として、とくにアルブミン(分
子量67000〜68000)より小さい分子量の血漿蛋白
質を直接血液潅流法によつて吸着除去するための
吸着材として使用したばあいの圧力損失が大きく
なり、溶血がおこりやすくなるなどの問題が生じ
やすくなる。また600μmをこえると比表面積が小
さくなり、吸着速度が小さくなるので、血液の循
環量の割に不要物の吸着除去量が少なくなる。 When the number average particle size is less than 300 μm, plasma proteins with a molecular weight smaller than albumin (molecular weight 67,000 to 68,000) can be directly perfused as cellulose particles for an adsorbent to selectively remove plasma proteins from blood. When used as an adsorbent for removal by adsorption, the pressure loss increases and problems such as hemolysis are more likely to occur. Moreover, when the diameter exceeds 600 μm, the specific surface area becomes small and the adsorption speed becomes low, so the amount of adsorption and removal of unnecessary substances becomes small in relation to the amount of blood circulation.
また、数平均粒径の±10%以内の粒子の割合が
95%未満しかないばあいには、前記のごとき吸着
体用の吸着材として使用したばあいに圧力損失が
大きくなつたり、溶血がおこりやすくなつたりし
やすくなる。 In addition, the percentage of particles within ±10% of the number average particle size is
If it is less than 95%, when used as an adsorbent for the above-mentioned adsorbent, pressure loss will increase and hemolysis will easily occur.
さらに、分配係数が分子量10000以下に対して
0.3以上、分子量100000以上に対して0.05以下の
範囲をはずれるばあいには、前記のごとき吸着体
用の吸着材として使用したばあいの選択性が低下
し、アルブミン以上の分子量のものも吸着されや
すくなつたり、逆に著しく吸着速度が小さくな
り、不要物の吸着除去が充分行なわれなくなるな
どの問題が生じやすくなる。 Furthermore, for molecular weights below 10,000, the distribution coefficient
If it is outside the range of 0.3 or more and 0.05 or less with respect to the molecular weight of 100,000 or more, the selectivity when used as an adsorbent for the adsorbent described above will decrease, and substances with a molecular weight of more than albumin will be easily adsorbed. Problems such as deterioration or conversely a marked decrease in the adsorption rate, such as insufficient adsorption and removal of unnecessary substances, tend to occur.
なおセルロース系粒子内部の網目状組織の網目
の大きさが0.1μm未満になると、吸着体用の吸着
材として用いたばあいに血液中の前記不要物の吸
着速度が小さくなるのみならず、これら不要物の
吸着除去が充分行なわれなくなるなどの傾向が生
じる。また10μmをこえると機械的強度が充分で
なくなり、カラムへの充填時や輸送時などに粒子
が変形したり、破砕されたりしやすくなる傾向が
生じ、またこのような変形が発生したばあいには
圧力損失が増大したり、微小な破片が血液中に混
入する傾向が生じる。 Note that if the mesh size of the network structure inside the cellulose particles is less than 0.1 μm, when used as an adsorbent for an adsorbent, not only will the rate of adsorption of the unnecessary substances in the blood become low, but also these There is a tendency that unnecessary substances are not adsorbed and removed sufficiently. Furthermore, if the particle size exceeds 10 μm, the mechanical strength will not be sufficient, and the particles will tend to be easily deformed or crushed during packing into a column or during transportation, and if such deformation occurs, This results in increased pressure loss and a tendency for microscopic debris to enter the blood.
つぎに本発明のセルロース系粒子の製法につい
て説明する。 Next, the method for producing cellulose particles of the present invention will be explained.
本発明のセルロース系粒子は、セルロース、セ
ルロース誘導体などを溶解させたポリマー溶液
を、たとえば特開昭62−191033号公報に記載の装
置および方法(振動法と乾湿式凝固法とを組合わ
せた方法)を適用することにより製造されうる。 The cellulose-based particles of the present invention can be obtained by dissolving a polymer solution in which cellulose, cellulose derivatives, etc. ) can be manufactured by applying.
前記ポリマー溶液を調製する際に用いる溶剤と
しては、セルロースの溶剤となる、たとえば銅ア
ンモニア水溶液、ジメチルスルホキシドとパラホ
ルムアルデヒドとの混合液、チオシアン酸カルシ
ウム水溶液など、また代表的なセルロース誘導体
である酢酸セルロースの溶剤となる、たとえばジ
メチルスルホキシド、ジメチルホルムアミド、ジ
メチルアセトアミド、N−メチル−2−ピロリド
ン、アセトンなどがあげられる。 Examples of the solvent used in preparing the polymer solution include cellulose solvents such as aqueous copper ammonia solution, a mixture of dimethyl sulfoxide and paraformaldehyde, and an aqueous calcium thiocyanate solution, as well as cellulose acetate, which is a typical cellulose derivative. Examples of solvents include dimethyl sulfoxide, dimethylformamide, dimethylacetamide, N-methyl-2-pyrrolidone, and acetone.
これらの溶剤には、えられるセルロース系粒子
のスキン層の厚さや内部の網目状組織の孔の大き
さを調節してから分配係数などを調節するため
に、メタノール、エタノール、エチレングリコー
ル、プロピレングリコール、グリセリン、水、無
機塩類、ポリエチレングリコール、ポリビニルピ
ロリドンなどを加えてもよい。 These solvents include methanol, ethanol, ethylene glycol, and propylene glycol in order to adjust the thickness of the skin layer and the pore size of the internal network structure of the resulting cellulose particles, and then adjust the partition coefficient. , glycerin, water, inorganic salts, polyethylene glycol, polyvinylpyrrolidone, etc. may be added.
このようにして調製されたポリマー溶液は、た
とえば特開昭62−191033号公報に記載のごとき装
置を用いて均一な小滴として気相中に噴出せしめ
られ、ほぼ球形になる飛行距離以上を飛行せしめ
られたのち凝固剤と接触せしめられる。このよう
にして製造されるセルロース系粒子はほぼ真球の
粒子である。 The polymer solution prepared in this way is ejected into the gas phase as uniform droplets using a device such as that described in JP-A No. 62-191033, and is flown over a flight distance in which it becomes approximately spherical. After that, it is brought into contact with a coagulant. The cellulose-based particles produced in this manner are approximately perfectly spherical particles.
前記凝固剤はポリマーの非溶剤からなるが、小
滴を構成する溶剤と溶けあい、小滴が自然にぬれ
るような表面張力を有するものが好ましい。この
ような凝固剤の具体例として、たとえば水、水と
前記良溶剤あるいは非溶剤との混合液、水と界面
活性剤との混合液などがあげられる。 The coagulant is made of a polymeric non-solvent, and preferably has a surface tension such that it dissolves in the solvent constituting the droplets and naturally wets the droplets. Specific examples of such coagulants include water, a mixture of water and the aforementioned good solvent or non-solvent, and a mixture of water and a surfactant.
一般にポリマー溶液中のポリマーの濃度が高
く、非溶剤の割合が少なく、水のように凝固力の
強い凝固液を使用するとスキン層の孔が小さくな
る(分配係数が小さくなる)。 Generally, when the concentration of the polymer in the polymer solution is high, the proportion of non-solvent is low, and a coagulating liquid with strong coagulating power, such as water, is used, the pores of the skin layer become smaller (the distribution coefficient becomes smaller).
このようにしてえられた本発明のセルロース系
粒子は特定の平均粒径および特定の粒径分布を有
し、かつ特定の分配係数を有するため、クロマト
グラフ用充填材、酵素固定用担体、アフイニテイ
クロマトグラフイー用担体、直接血液潅流用の吸
着体などの用途に使用することができ、これらの
用途に使用したばあいには圧力損失、選択性、吸
着速度などの点で優れたものとなる。 The cellulose-based particles of the present invention obtained in this way have a specific average particle size, a specific particle size distribution, and a specific distribution coefficient, so they can be used as packing materials for chromatography, carriers for enzyme immobilization, and after-sampling. It can be used for applications such as a carrier for initake chromatography and an adsorbent for direct blood perfusion, and when used in these applications, it has excellent properties such as pressure drop, selectivity, and adsorption speed. Become.
つぎに本発明のセルロース系粒子を実施例に基
づき説明するが、本発明がこれら実施例に限定さ
れないことは勿論である。 Next, the cellulose particles of the present invention will be explained based on Examples, but it goes without saying that the present invention is not limited to these Examples.
実施例 1
二酢酸セルロースを濃度が12.5%(重量%、以
下同様)となるようにジメチルスルホキシド/プ
ロピレングリコールが重量比で4/6の混合液に溶
解させた。Example 1 Cellulose diacetate was dissolved in a mixed solution of dimethyl sulfoxide/propylene glycol in a weight ratio of 4/6 so that the concentration was 12.5% (weight %, the same applies hereinafter).
ノズルの前方5mmのところに2cmの間隔を離し
て、巾5cm、液滴の進行方向の長さ25cmの大きさ
の平行平板状の電極を設置し、該電極とノズルと
の間に800Vの直流電圧を印加した。このノズル
に設けた直径250μmのオリフイスから、145℃に
保持した前記溶液を7.8m/secの線速で3850Hzの
振動を加えながら吐出させ、該溶液の均一な液滴
を形成させ、空気中を約3m飛行させたのち、23
℃の10%メタノール水溶液中へ侵入させて凝固さ
せ、2酢酸セルロースの粒子をえた。 Parallel plate electrodes with a width of 5 cm and a length of 25 cm in the direction of droplet travel are installed 5 mm in front of the nozzle at a distance of 2 cm, and a DC voltage of 800 V is applied between the electrodes and the nozzle. A voltage was applied. From an orifice with a diameter of 250 μm provided in this nozzle, the solution maintained at 145°C is ejected at a linear velocity of 7.8 m/sec while applying vibrations of 3850 Hz to form uniform droplets of the solution, which are dispersed in the air. After flying about 3m, 23
The particles were coagulated by entering a 10% aqueous methanol solution at ℃ to obtain particles of cellulose diacetate.
えられた二酢酸セルロース粒子を50℃、0.6%
のカ性ソーダ水溶液に投入して、2時間攪拌した
のち回収し、中和・水洗して、ほぼ100%再生さ
れた再生セルロース粒子をえた。 The obtained cellulose diacetate particles were heated at 50℃ and 0.6%
The cellulose particles were poured into an aqueous solution of caustic soda, stirred for 2 hours, recovered, neutralized and washed with water to obtain almost 100% regenerated cellulose particles.
えられた再生セルロース粒子の数平均粒径を下
記方法により測定したところ、430μmで、粒子が
すべて数平均粒径±5%以内にあつた。 The number average particle size of the obtained regenerated cellulose particles was measured by the method described below and was found to be 430 μm, which was within ±5% of the number average particle size.
えられた再生セルロース粒子内の液体をエタノ
ールで置換してから炭酸ガス臨界点乾燥((株)日立
製作所製の臨界点乾燥器HCP−2を使用)させ、
金を蒸着させたのち走査型電子顕微鏡で観察した
ところ、第1図に示すように表面に厚さ約0.2μm
のスキン層(上端左から約1/3の部分から左端上
から約1/2の部分にかけて斜に存在する白つぽい
層のうちの表面部分)があり、第2図に示すよう
に内部は孔径が約0.2〜2μmの多孔質網目状組織
であつた。 After replacing the liquid in the obtained regenerated cellulose particles with ethanol, they are subjected to critical point drying with carbon dioxide gas (using a critical point dryer HCP-2 manufactured by Hitachi, Ltd.),
After depositing gold, observation using a scanning electron microscope revealed that the surface had a thickness of about 0.2 μm, as shown in Figure 1.
There is a skin layer (the surface part of the whitish layer that exists diagonally from about 1/3 from the top left to about 1/2 from the top left), and as shown in Figure 2, the inside is It had a porous network structure with a pore diameter of about 0.2 to 2 μm.
分子量10000、110000のデキストランに対する
該粒子の分配係数を下記方法により測定したとこ
ろ、それぞれ0.67および0であつた。 The distribution coefficients of the particles for dextrans with molecular weights of 10,000 and 110,000 were measured by the following method and were 0.67 and 0, respectively.
前記再生セルロース粒子を内径14mm、長さ7cm
のカラムに充填し、ヘパリンを30ユニツト/ml加
えた牛の新鮮血を37℃に保温して流し、徐々に流
量を大きくして圧力損失を測定したところ、線速
の増加と共にほぼ直線的に圧力損失が大きくなつ
たが、8cm/minのときでも50mmHgで、そのま
ま1時間連続運転してもこの値はほとんど変わら
ず、直接血液潅流可能であつた。 The regenerated cellulose particles had an inner diameter of 14 mm and a length of 7 cm.
Fresh bovine blood packed into a column with 30 units/ml of heparin added was kept at 37°C, and the pressure drop was measured by gradually increasing the flow rate.As the linear velocity increased, the pressure drop was almost linear. Although the pressure loss increased, the pressure was 50 mmHg even at 8 cm/min, and this value remained almost unchanged even after continuous operation for 1 hour, and direct blood perfusion was possible.
前記再生セルロース粒子をエピクロルヒドリン
と反応させ、ついでn−ヘキシルアミンと反応さ
せて、n−ヘキシルアミン固定化セルロース粒子
をえた。この粒子の選択性を下記方法により測定
したところ、リゾチーム、アルブミンに対する吸
着率はそれぞれ73%および8%であつた。 The regenerated cellulose particles were reacted with epichlorohydrin and then with n-hexylamine to obtain n-hexylamine-immobilized cellulose particles. When the selectivity of these particles was measured by the method described below, the adsorption rates for lysozyme and albumin were 73% and 8%, respectively.
(数平均粒径および粒径分布)
数百個(約500〜1000個)の粒子の光学顕微鏡
像を画像処理装置((株)ニレコ製のルーゼツクス
)を使用して処理して求める。(Number average particle size and particle size distribution) Optical microscopic images of several hundred particles (approximately 500 to 1000 particles) are processed using an image processing device (Ruzetskus manufactured by Nireco Co., Ltd.).
(分配係数(Kav))
種々の分子量のデキストランおよびプルランの
水溶液を用いて分配クロマトグラフイーを行な
い、溶出曲線を求めて式:
Kav=Ve−Vo/Vt−Vo
(式中、Voは分子量2000000のデキストランの溶
出曲線のピーク位置に相当する溶出液量、Vtは
カラム体積、Veは試料の溶出曲線のピーク位置
に相当する溶出液量)から求める。(Partition coefficient (Kav)) Partition chromatography was performed using aqueous solutions of dextran and pullulan with various molecular weights, and the elution curve was determined using the formula: Kav=Ve−Vo/Vt−Vo (wherein, Vo is the molecular weight of 2,000,000 (Vt is the column volume, Ve is the eluate volume corresponding to the peak position of the elution curve of the sample).
(選択性)
PH7.4に調整した0.025Mリン酸緩衝液にリゾチ
ームおよびアルブミンをそれぞれ3mg/mlおよび
7.3mg/mlの濃度になるように溶解させた各々の液
6容量に対し、沈降体積として1容量の割合にな
るようにに血漿蛋白質に吸着性を有するリカンド
を固定したセルロース系粒子を加え、37℃で2時
間振盪したのち、上澄液の濃度を測定してそれぞ
れの吸着率を求める。(Selectivity) Lysozyme and albumin were added at 3 mg/ml and 3 mg/ml, respectively, in 0.025 M phosphate buffer adjusted to pH 7.4.
To 6 volumes of each solution dissolved to a concentration of 7.3 mg/ml, cellulose-based particles on which a liquid adsorbing to plasma proteins is immobilized are added so as to have a sedimentation volume of 1 volume. After shaking at 37°C for 2 hours, the concentration of the supernatant liquid was measured to determine the respective adsorption rates.
吸着率(%)=原液濃度−上澄液濃度/原液濃度×10
0
(直接血液潅流の可能性の判断)
ヘパリンを30ユニツト/ml加えた牛の新鮮血を
37℃に保温して、粒子を充填した長さ7cm、内径
14mmφのカラムに徐々に流量を増加させながら線
速度が8cm/minになるまで流して、この間に圧
力損失が100mmHgをこえないものを直接血液潅流
が可能であると判断した。 Adsorption rate (%) = Stock solution concentration - Supernatant solution concentration / Stock solution concentration x 10
0 (Determining the possibility of direct blood perfusion) Fresh cow blood to which 30 units/ml of heparin was added was added.
Insulated at 37℃ and filled with particles, length 7cm, inner diameter
The flow rate was gradually increased through a 14 mmφ column until the linear velocity reached 8 cm/min, and direct blood perfusion was judged to be possible if the pressure drop did not exceed 100 mmHg during this time.
比較例 1
数平均粒径が450μmで、89%の粒子が数平均粒
径の±10%以内にある市販の再生セルロース粒子
を用いて実施例1と同様にして圧力損失を測定し
たところ、線速が2cm/minですでに圧力損失が
100mmHgをこえ、そののちさらに圧力損失が大き
くなつたので実験を中止した。Comparative Example 1 Pressure drop was measured in the same manner as in Example 1 using commercially available regenerated cellulose particles with a number average particle size of 450 μm and 89% of the particles falling within ±10% of the number average particle size. At a speed of 2 cm/min, there is already a pressure loss.
The pressure drop exceeded 100 mmHg, and the experiment was discontinued as the pressure loss became even larger.
比較例 2
均一な液滴の形成条件を変更して実施例1と同
様にして数平均粒径が270μmで100%の粒子が数
平均粒径の±5%以内にある再生セルロース粒子
をえた。この粒子を用いて実施例1と同様にして
圧力損失を測定したところ、線速が5cm/minの
ところで100mmHgをこえた。Comparative Example 2 Regenerated cellulose particles with a number average particle size of 270 μm and 100% of the particles within ±5% of the number average particle size were obtained in the same manner as in Example 1 by changing the conditions for forming uniform droplets. When the pressure drop was measured using these particles in the same manner as in Example 1, it exceeded 100 mmHg at a linear velocity of 5 cm/min.
比較例 3
分子量110000のデキストランに対する分配係数
が0.3の市販の再生セルロース粒子に実施例1の
ばあいと同様にしてn−ヘキシルアミンを固定化
してリゾチームとアルブミンとの吸着率を測定し
たところ、それぞれ24%および58%であつた。Comparative Example 3 When n-hexylamine was immobilized on commercially available regenerated cellulose particles with a distribution coefficient of 0.3 for dextran having a molecular weight of 110,000 in the same manner as in Example 1, the adsorption rates of lysozyme and albumin were measured. They were 24% and 58%.
本発明のセルロース系粒子は特定の数平均粒径
および特定の粒径分布を有し、かつ特定の分配係
数を有するため、血液中から血漿蛋白質を選択的
に除くための吸着体用のセルロース系粒子、とく
にアルブミンより小さい分子量の血漿蛋白質を直
接血液潅流法によつて吸着除去するなどの用途に
用いたばあいには、圧力損失が小さく、溶血など
の問題が生じにくくなる、選択性も向上し、吸着
量も多くなるなどの効果が達成される。
Since the cellulose-based particles of the present invention have a specific number average particle size, a specific particle size distribution, and a specific distribution coefficient, the cellulose-based particles can be used as an adsorbent for selectively removing plasma proteins from blood. When used for adsorption and removal of particles, especially plasma proteins with a molecular weight smaller than albumin, by direct blood perfusion, pressure loss is small, problems such as hemolysis are less likely to occur, and selectivity is improved. However, effects such as an increase in adsorption amount are achieved.
第1図は本発明のセルロース系粒子の構造を説
明するための写真であり、粒子断面の表面付近
(表面のスキン層およびその内側の網目状構造)
を15000倍に拡大した写真、第2図は実施例1で
えられた本発明のセルロース系粒子の内部構造を
説明するための写真であり、粒子断面を15000倍
に拡大した写真である。
Figure 1 is a photograph for explaining the structure of the cellulose-based particles of the present invention, showing the vicinity of the surface of the particle cross section (the skin layer on the surface and the network structure inside).
FIG. 2 is a photograph for explaining the internal structure of the cellulose-based particles of the present invention obtained in Example 1, and is a photograph in which the particle cross section is magnified 15,000 times.
Claims (1)
%以上の粒子が数平均粒径の±10%以内にあり、
分配係数が分子量10000以下に対して0.3以上、分
子量100000以上に対して0.05以下であるセルロー
ス系粒子。1 Number average particle size is in the range of 300 to 600μm, 95
% or more of the particles are within ±10% of the number average particle size,
Cellulose particles with a distribution coefficient of 0.3 or more for molecular weights of 10,000 or less and 0.05 or less for molecular weights of 100,000 or more.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10534688A JPH01275601A (en) | 1988-04-27 | 1988-04-27 | Cellulose particle |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10534688A JPH01275601A (en) | 1988-04-27 | 1988-04-27 | Cellulose particle |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01275601A JPH01275601A (en) | 1989-11-06 |
JPH0587081B2 true JPH0587081B2 (en) | 1993-12-15 |
Family
ID=14405174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10534688A Granted JPH01275601A (en) | 1988-04-27 | 1988-04-27 | Cellulose particle |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01275601A (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69835275T2 (en) | 1997-01-07 | 2007-07-19 | Kaneka Corp. | ABSORBENT FOR CLEANING BODY FLUIDS |
US8272518B2 (en) | 2004-07-23 | 2012-09-25 | Kaneka Corporation | Direct hemoperfusion adsorber packed with adsorbent having water insoluble microparticle removed therefrom, and method of obtaining direct hemoperfusion adsorbent having water insoluble microparticle removed therefrom |
JP4949230B2 (en) * | 2005-03-03 | 2012-06-06 | 株式会社カネカ | Cell preparation method and apparatus |
JP2013010701A (en) * | 2011-06-28 | 2013-01-17 | Jnc Corp | Endotoxin adsorbent,column for whole blood perfusion type extracorporeal circulation using the same, and chromatography filler for purifying pharmaceutical drug |
JP6285413B2 (en) * | 2013-02-25 | 2018-02-28 | テルモ株式会社 | Polysaccharide powder and anti-adhesion material containing the same |
WO2017073626A1 (en) * | 2015-10-30 | 2017-05-04 | 東レ株式会社 | Cellulose ether derivative fine particles |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5757556A (en) * | 1980-09-25 | 1982-04-06 | Asahi Chemical Ind | Blood purifying method and apparatus |
JPS62191033A (en) * | 1986-02-06 | 1987-08-21 | Kanegafuchi Chem Ind Co Ltd | Method for forming uniform liquid droplet |
-
1988
- 1988-04-27 JP JP10534688A patent/JPH01275601A/en active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5757556A (en) * | 1980-09-25 | 1982-04-06 | Asahi Chemical Ind | Blood purifying method and apparatus |
JPS62191033A (en) * | 1986-02-06 | 1987-08-21 | Kanegafuchi Chem Ind Co Ltd | Method for forming uniform liquid droplet |
Also Published As
Publication number | Publication date |
---|---|
JPH01275601A (en) | 1989-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5993661A (en) | Macroporous or microporous filtration membrane, method of preparation and use | |
JP4355655B2 (en) | Functional porous fiber | |
US4840733A (en) | Fine porous membrane and process for producing the same | |
JP7270993B2 (en) | Structurally controllable ion-exchange nanofiber skeleton three-dimensional separation material and its manufacturing method | |
JPH01148305A (en) | High molecular porous hollow yarn and process for removing virus utilizing the same | |
US20220025131A1 (en) | Method for producing cellulose beads | |
WO1998030620A1 (en) | Cellulosic particles, spherical object comprising cross-linked polymer particles, and adsorbent for body fluid purification | |
SE452161B (en) | PROCEDURE FOR THE PREPARATION OF POROSA CELLULOSAPERLOR AND ITS USE | |
US5387345A (en) | Cellulose acetate membranes | |
JPS6214642B2 (en) | ||
JPH0587081B2 (en) | ||
WO2016159334A1 (en) | Method for producing porous cellulose medium | |
US6174443B1 (en) | Purification of wheat germ agglutinin using macroporous or microporous filtration membrane | |
CN115569521A (en) | Cellulose composite ultrafiltration membrane and preparation method thereof | |
JPH01278534A (en) | Bimodal particle | |
JP3941980B2 (en) | Cellulosic carrier and method for producing the same | |
JPH0631145A (en) | Dialyzer consisting of cellulose acetate or cellulose acetate derivative and having interior through space as in form of hollow fiber and its production | |
JPH05168878A (en) | Antimicrobial liquid separation membrane | |
JPH01277570A (en) | Beta2-microglobulin adsorbent for extracorporeal circulation treatment | |
JPH01275641A (en) | Polymer particle | |
JP3941978B2 (en) | Cellulosic particles and method for producing the same | |
JP3086739B2 (en) | Manufacturing method of high strength cellulosic gel | |
EP3549623A1 (en) | Blood component selective adsorption filtering medium and blood filter | |
JP2803142B2 (en) | Method for producing polysulfone hollow fiber membrane | |
KR20240114106A (en) | Fabrication method of porous carbon particles in fiber preform and carbide-base composite using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |